Investor Stock List
Ranked #1,936 of 8,699 institutional investors

Bain Capital Life Sciences Investors, LLC

Boston, MA

$1.35B
US stock portfolio at live prices · today −$29.9M (−2.17%)
Live prices, last trade 12:49 PM ET
Value at quarter end (Q3 2026)
$1.49B
Change from Q2 2026
−$192.2M (−11.43%)
Positions
19 · 4 new, 2 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$298M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
KLRA 19.1%HTFL 15.2%ADRX 6.70%TARS 6.07%SVRA 5.58%
StockSharesValue, live% of portfoliovs Q2 2026
KLRA Kailera Therapeutics, Inc.22,583,268$257M19.1%Unchanged
HTFL Heartflow, Inc.4,448,158$205M15.2%Reduced −47%
ADRX ADARx Pharmaceuticals, Inc.6,728,970$90.2M6.70%New
TARS Tarsus Pharmaceuticals, Inc.1,096,141$81.8M6.07%New
SVRA Savara Inc.17,600,621$75.2M5.58%Unchanged
COAG Hemab Therapeutics Holdings, Inc.1,650,000$65.5M4.86%Unchanged
SLDB Solid Biosciences Inc.9,808,819$61.2M4.54%Unchanged
OLMA Olema Oncology, Inc.7,085,249$50.4M3.74%Unchanged
DYN Dyne Therapeutics, Inc.1,900,000$29.9M2.22%New
XFOR X4 Pharmaceuticals, Inc.7,967,454$23.7M1.76%Unchanged
FRNM Freenome, Inc.2,365,459$22.4M1.66%New
CABA Cabaletta Bio, Inc.21,209,188$20.3M1.51%Added +23%
CCCC C4 Therapeutics, Inc.7,171,910$17.9M1.33%Unchanged
ANNX Annexon, Inc.4,437,731$13.9M1.03%Unchanged
IRON Disc Medicine, Inc.141,234$10.6M0.79%Unchanged
AVIR Atea Pharmaceuticals, Inc.2,075,639$8.1M0.60%Unchanged
RPID Rapid Micro Biosystems, Inc.8,434,560$6.2M0.46%Unchanged
KYTX Kyverna Therapeutics, Inc.1,312,000$5.6M0.41%Reduced −55%
XLO Xilio Therapeutics, Inc.664,021$4.9M0.36%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
DNTH Dianthus Therapeutics, Inc.362,470$30.5M
UPB Upstream Bio, Inc.600,949$1.1M